Work

Safety and Durability of Ponatinib in Patients With Philadelphia Chromosome–Positive (Ph+) Leukemia: Long-term Follow-up of an Ongoing Phase 1 Study

Year: 2014

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/j.clml.2014.06.069

Authors: Michael J. Mauro, Jorge E. Cortes, Hagop M. Kantarjian, Neil P. Shah, Dale Bixby, Ian W. Flinn, Thomas O’Hare, Simin Hu, Victor M. Rivera, Tim Clackson, Christopher D. Turner, Frank G. Haluska, Brian J. Druker, Michael W. Deininger, Moshe Talpaz

Institutions: Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, University of California, San Francisco, University of Michigan, U-M Rogel Cancer Center, Sarah Cannon, Huntsman Cancer Institute, OHSU Knight Cancer Institute, ARIAD Pharmaceuticals (United States)

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2117691239

FWCI: 0.205

Cites:

Cited by: 1

Related to: 10